GlassScriptPhysician profile
Samuel M Overholt
NPI 1417952482
$3,143.49
in general payments reported to CMS, 2019-2025
26 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $140 · 2021: $263 · 2022: $705 · 2023: $407 · 2024: $472 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,293 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,292.65 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $722.77 | 2019-2025 | Clarifix, Clarifix Cryotherapy Device |
| Regeneron Healthcare Solutions, INC. | $483.40 | 2021-2025 | Dupixent |
| Genzyme Corporation | $322.08 | 2021-2025 | |
| Glaxosmithkline, LLC. | $313.01 | 2021-2025 | Nucala |
| Intersect Ent, INC. | $308.11 | 2019-2022 | |
| Acclarent, INC | $168.21 | 2019-2021 | |
| Optinose US, INC. | $131.77 | 2020-2025 | |
| Olympus America INC. | $126.25 | 2019-2025 | Olympus, Hd Camera Head, Evis Exera III Bronchovideoscope |
| Sanofi-Aventis U.S. LLC | $79.99 | 2024 | |
| Neurent Medical Limited | $62.84 | 2022-2025 | Neuromark System, Neuromark Radiofrequency Console |
| Acera Surgical, INC. | $53.94 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $47.01 | 2022-2025 | Stealthstation S8 Platform, Propel |
| Pfizer INC. | $44.68 | 2024 | |
| Novartis Pharmaceuticals Corporation | $42.77 | 2019 | |
| Integra Lifesciences Corporation | $40.74 | 2022-2024 | Trudi Probe, Inspira Air, Acclarent Aera |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $32.01 | 2024 | Inspire |
| Greer Laboratories, INC. | $21.91 | 2019 | |
| Amgen INC. | $20.16 | 2025 | Tezspire |
| Ambu INC. | $17.57 | 2021 | |
| Sanara Medtech INC. | $17.14 | 2023 | Celleraterx |
| Genentech USA, INC. | $16.93 | 2019 | |
| Hikma Pharmaceuticals USA | $16.92 | 2025 | Ryaltris |
| Arbor Pharmaceuticals, INC. | $15.55 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.50 | 2022 | |
| Covidien LP | $12.62 | 2019 | |
| Resmed Corp | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Overholt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.